goodlab.org

What It Is

GoodLab is a digital platform/service provider focused on clinical trial patient recruitment. It is operated by ITS Limited, with its team based in Sydney, Australia. Its goal is to help sponsors, CROs, research centers, and site networks reach patient populations that were previously unaware of clinical trial opportunities. According to the website, it is trusted by 20,000 people daily, generates 600,000 new candidates per month, covers 153 therapeutic areas, and has participated in 550+ clinical trials.

Core Capabilities

Based on publicly available information, GoodLab’s core offering is not a traditional CRM or CTMS, but rather the patient acquisition and conversion pipeline: a trial discovery platform, online marketing traffic, digital pre-screening, custom landing pages, feasibility testing, call center handoff, site handover, and referral distribution. Multiple case studies show that it can launch a trial within 24 hours of receiving IRB-approved materials, set lead caps based on site budgets, and push some leads in real time or integrate them into a site CMS.

Pricing and Business Model

The website does not publish standard packages. Case studies suggest that its pricing is flexible and may be based on randomized patients, successfully screened-on-site patients, or referrals. Some projects have no setup fees and also support budget caps by site. This is attractive to CROs and sponsors that want to tie costs to recruitment outcomes, but buyers still need to request a quote to confirm unit pricing, minimum budgets, and SLAs.

Pros and Cons

Its strengths lie in deep vertical experience and relatively concrete public case data. For example, an asthma project achieved 3 randomized patients per day, a vaccine project delivered 374 randomized patients in 3 months, and an eczema project clearly reported conversion data from phone screening to site referrals. It also covers both common and rare diseases, and emphasizes reaching people not covered by traditional Facebook ads or existing databases.

The drawbacks are also clear: it does not disclose details about its backend product, permissions, reporting, security compliance, API documentation, or standard integration list. For medical data and patient privacy handling, only its Privacy Policy, Terms, and descriptions of IRB material usage are visible, making it impossible to confirm compliance status for HIPAA, SOC 2, GDPR, or similar standards.

Best Fit and Access from China

GoodLab is suitable for sponsors, CROs, site networks, and teams with patient recruitment needs for U.S. or multi-site clinical trials, especially those looking to reduce recruitment risk through performance-based pricing. Its accessibility from China cannot be determined from the crawled text. Its case studies are mainly focused on U.S. patients and U.S. research, so domestic trial deployment and local compliance capabilities would need to be verified separately.